New York tries targeted lockdowns, India tops seven million cases, and monoclonal antibodies may be a boon for science and yet a challenge for public health- Tech in Two

Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt

Learn about your ad choices: dovetail.prx.org/ad-choices